FAM
TERN

Fred Alger Management’s Terns Pharmaceuticals TERN Stock Holding History

Fred Alger Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.49M Sell
47,151
-42,721
-48% -$1.75M 0.01% 294
2025
Q4 		$3.63M Buy
+89,872
New +$2.08M 0.01% 271
2023
Q2 		– Sell
-16,276
Closed -$193K – 568
2023
Q1 		$193K Buy
+16,276
New +$156K ﹤0.01% 424

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Fred Alger Management's TERN Position: Q1 2026 in Review

Fred Alger Management reduced its Terns Pharmaceuticals (TERN) stake by 48% in Q1 2026, selling an estimated $1.75M and leaving 47,151 shares worth $2.49M. The position accounts for 0.01% of the portfolio, ranked #294.

Fred Alger Management first reported a position in TERN in Q1 2023 and has held it in 3 quarters since. The position peaked at $3.63M in Q4 2025. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Fred Alger Management held 47,151 shares of Terns Pharmaceuticals worth $2.49M as of Q1 2026.
  • Fred Alger Management sold 42,721 Terns Pharmaceuticals shares in Q1 2026, an estimated $1.75M.
  • Terns Pharmaceuticals made up 0.01% of Fred Alger Management's portfolio in Q1 2026, its #294 holding.
  • Fred Alger Management first reported a position in Terns Pharmaceuticals in Q1 2023 and has held it in 3 quarters since.
  • Fred Alger Management's Terns Pharmaceuticals position peaked at $3.63M in Q4 2025.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.